CAS: 1062271-24-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | MK6-83 REF: AN-AG00952WCAS: 1062271-24-2 | ≥98%(HPLC) | 131,00 €~745,00 € | Jue 02 May 24 |
 | MK6-83 REF: TM-T24477CAS: 1062271-24-2 | 99.71% | 48,00 €~551,00 € | Jue 09 May 24 |
 | MK6-83 REF: TR-M424600CAS: 1062271-24-2 | - - - | 142,00 €~828,00 € | Mié 12 Jun 24 |
| MK6-83-d10 REF: TR-M424602CAS: 1062271-24-2 | - - - | 3.559,00 € | Mié 12 Jun 24 |
 | MK6-83 REF: 3D-MSB27124CAS: 1062271-24-2 | Min. 95% | A consultar | Jue 13 Jun 24 |
MK6-83
CAS:1062271-24-2
Fórmula:
C16H20N2O2S2
Pureza:
≥98%(HPLC)
Forma y color:
Solid
Peso molecular:
336.4722
Ref: AN-AG00952W
| 1mg | 131,00 € | |
| 5mg | 164,00 € | |
| 10mg | 260,00 € | |
| 25mg | 658,00 € | |
| 50mg | 745,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
MK6-83
CAS:1062271-24-2
MK6-83 is the transient receptor potential channel ML3 agonist.
Fórmula:
C16H20N2O2S2
Pureza:
99.71%
Forma y color:
Solid
Peso molecular:
336.47
Ref: TM-T24477
| 2mg | 48,00 € | |
| 5mg | 72,00 € | |
| 10mg | 94,00 € | |
| 25mg | 183,00 € | |
| 50mg | 321,00 € | |
| 100mg | 551,00 € | |
| 1ml*10 (DMSO) | 79,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
MK6-83
Producto controladoCAS:1062271-24-2
Applications MK6-83 is a TRPML channel activator, restoring endolysosomal trafficking and zinc homeostasis lysosomes of …
Fórmula:
C16H20N2O2S2
Forma y color:
Pale Brown Solid
Peso molecular:
336.47
Ref: TR-M424600
| 5mg | 142,00 € | |
| 10mg | 219,00 € | |
| 50mg | 828,00 € |
Entrega estimada en Estados Unidos, el Miércoles 12 de Junio de 2024
MK6-83
CAS:1062271-24-2
MK6-83 is a synthetic molecule that has been shown to have antimicrobial activity. It inhibits …
Fórmula:
C16H20N2O2S2
Pureza:
Min. 95%
Peso molecular:
336.47 g/mol
Ref: 3D-MSB27124
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
